谷歌浏览器插件
订阅小程序
在清言上使用

A Randomized, Non-Comparative, Phase II Study of Maintenance OSE2101 Vaccine Alone or in Combination with Nivolumab (nivo) or FOLFIRI after Induction with FOLFIRINOX in Patients (pts) with Advanced Pancreatic Ductal Adenocarcinoma (apdac): First Interim Results of the TEDOPAM GERCOR D17-01 PRODIGE 63 STUDY.

Journal of Clinical Oncology(2022)

引用 0|浏览43
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要